Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F R Hatz

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
BMJ Open Diabetes Research & Care|May 23, 2020
Assessment of diabetes and prediabetes prevalence and predictors by HbA1c in a population from sub-Saharan Africa with a high proportion of anemia: a prospective cross-sectional studyNikolai Carl Hodel, Ali Hamad, Klaus Reither, et al.
Vaccine|July 12, 2015
Safety and immunogenicity of a candidate bioconjugate vaccine against Shigella dysenteriae type 1 administered to healthy adults: A single blind, partially randomized Phase I studyChristoph F R Hatz, Bettina Bally, Susanne Rohrer, et al.
Plos One|November 1, 2018
The epidemiology of chronic kidney disease and the association with non-communicable and communicable disorders in a population of sub-Saharan AfricaNikolai C Hodel, Ali Hamad, Claudia Praehauser, et al.
Therapeutische Umschau. Revue Therapeutique|July 10, 2001
[Malaria--chemoprophylaxis 2001]F R Hatz, B Beck, J Blum, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
BMJ Open Diabetes Research & Care|May 23, 2020
Assessment of diabetes and prediabetes prevalence and predictors by HbA1c in a population from sub-Saharan Africa with a high proportion of anemia: a prospective cross-sectional studyNikolai Carl Hodel, Ali Hamad, Klaus Reither, et al.
Vaccine|July 12, 2015
Safety and immunogenicity of a candidate bioconjugate vaccine against Shigella dysenteriae type 1 administered to healthy adults: A single blind, partially randomized Phase I studyChristoph F R Hatz, Bettina Bally, Susanne Rohrer, et al.
Plos One|November 1, 2018
The epidemiology of chronic kidney disease and the association with non-communicable and communicable disorders in a population of sub-Saharan AfricaNikolai C Hodel, Ali Hamad, Claudia Praehauser, et al.
Therapeutische Umschau. Revue Therapeutique|July 10, 2001
[Malaria--chemoprophylaxis 2001]F R Hatz, B Beck, J Blum, et al.
Pageof 2